PTCL
Clinical trials for PTCL explained in plain language.
Never miss a new study
Get alerted when new PTCL trials appear
Sign up with your email to follow new studies for PTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy targets tough T-Cell cancers in early trial
Disease control Recruiting nowThis study tests a new type of CAR-T cell therapy that targets a protein called CD5 on cancer cells. It is for people with T-cell acute lymphoblastic leukemia or T-cell lymphoma that has come back or not responded to treatment. The trial has two phases: first, finding the safest …
Matched conditions: PTCL
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug cocktail aims to outsmart tough blood cancer
Disease control Recruiting nowThis study tests if a combination of two drugs (romidepsin and oral azacytidine) works better than standard single drugs for people with peripheral T-cell lymphoma (PTCL) that has returned or not responded to prior therapy. About 50 adults will be randomly assigned to either the …
Matched conditions: PTCL
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC